Cui Hao, Zhang Ke-Cheng, Cao Bo, Deng Huan, Liu Gui-Bin, Song Li-Qiang, Zhao Rui-Yang, Liu Yi, Chen Lin, Wei Bo
School of Medicine, Nankai University, Tianjin 300071, China.
Department of General Surgery and Institute of General Surgery, the First Medical Center, Chinese PLA General Hospital, Beijing 100853, China.
World J Gastrointest Surg. 2022 May 27;14(5):452-469. doi: 10.4240/wjgs.v14.i5.452.
Neoadjuvant chemotherapy (NACT) combined with surgery is regarded as an effective treatment for advanced gastric cancer (AGC). Laparoscopic surgery represents the mainstream of minimally invasive surgery. Currently, surgeons focus more on surgical safety and oncological outcomes of laparoscopic gastrectomy after NACT. Thus, we sought to evaluate short- and long-term outcomes between laparoscopic total gastrectomy (LTG) and open total gastrectomy (OTG) after NACT.
To compare the short and long-term outcomes between LTG and OTG for AGC after NACT.
We retrospectively collected the clinicopathological data of 136 patients who accepted gastrectomy after NACT from June 2012 to June 2019, including 61 patients who underwent LTG and 75 who underwent OTG. Clinicopathological characteristics between the LTG and OTG groups showed no significant difference. SPSS 26.0, R software, and GraphPad PRISM 8.0 were used to perform statistical analyses.
Of the 136 patients included, eight acquired pathological complete response, and the objective response rate was 47.8% (65/136). The LTG group had longer operation time ( = 0.015), less blood loss ( = 0.003), shorter days to first flatus ( < 0.001), and shorter postoperative hospitalization days ( < 0.001). LTG spent more surgical cost than OTG ( < 0.001), while total hospitalized cost of LTG was less than OTG ( < 0.001). 21 (28.0%) patients in the OTG group and 14 (23.0%) in the LTG group had 30-d postoperative complications, but there was no significant difference between the two groups ( = 0.503). The 3-year overall survival (OS) rate was 60.6% and 64.6% in the LTG and OTG groups, respectively [hazard ratio (HR) = 0.859, 95% confidence interval (CI): 0.522-1.412, = 0.546], while the 3-year disease-free survival (DFS) rate was 54.5% and 51.8% in the LTG and OTG group, respectively (HR = 0.947, 95%CI: 0.582-1.539, = 0.823). Multivariate cox analysis showed that body mass index and pTNM stage were independent risk factors for OS while vascular invasion and pTNM stage were independent risk factors for DFS ( < 0.05).
After NACT, LTG shows comparable 30-d postoperative morbidity as well as 3-year OS and DFS rate to OTG. We recommend that experienced surgeons select LTG other than OTG for proper AGC patients after NACT.
新辅助化疗(NACT)联合手术被认为是晚期胃癌(AGC)的有效治疗方法。腹腔镜手术是微创手术的主流。目前,外科医生更关注NACT后腹腔镜胃切除术的手术安全性和肿瘤学结局。因此,我们试图评估NACT后腹腔镜全胃切除术(LTG)和开放全胃切除术(OTG)的短期和长期结局。
比较NACT后AGC患者LTG和OTG的短期和长期结局。
我们回顾性收集了2012年6月至2019年6月接受NACT后胃切除术患者的临床病理资料,其中61例行LTG,75例行OTG。LTG组和OTG组的临床病理特征无显著差异。使用SPSS 26.0、R软件和GraphPad PRISM 8.0进行统计分析。
136例纳入患者中,8例获得病理完全缓解,客观缓解率为47.8%(65/136)。LTG组手术时间更长(P = 0.015),出血量更少(P = 0.003),首次排气时间更短(P < 0.001),术后住院天数更短(P < 0.001)。LTG的手术费用高于OTG(P < 0.001),而LTG的总住院费用低于OTG(P < 0.001)。OTG组21例(28.0%)患者和LTG组14例(23.0%)患者术后30天出现并发症,但两组之间无显著差异(P = 0.503)。LTG组和OTG组的3年总生存率(OS)分别为60.6%和64.6%[风险比(HR)= 0.859,95%置信区间(CI):0.522 - 1.412,P = 0.546],而LTG组和OTG组的3年无病生存率(DFS)分别为54.5%和51.8%(HR = 0.947,95%CI:0.582 - 1.539,P = 0.823)。多因素Cox分析显示,体重指数和pTNM分期是OS的独立危险因素,而血管侵犯和pTNM分期是DFS的独立危险因素(P < 0.05)。
NACT后,LTG术后30天发病率、3年OS率和DFS率与OTG相当。我们建议有经验的外科医生为合适的NACT后AGC患者选择LTG而非OTG。